PERFORMANCE / SINGLE
MELANOTAN 2
10MGImportant medical and research notice
This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A synthetic melanocortin-receptor agonist studied for stimulating melanin production independent of UV exposure.
Available Strengths
- 10MG (ML10)
Research Protocol
Reference loading schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Week 1 | 0.25 mg | 7.5 | 0.075 mL |
| Week 2 | 0.5 mg | 15 | 0.15 mL |
| Week 3 | 0.75 mg | 22.5 | 0.225 mL |
| Weeks 4–8 | 1 mg | 30 | 0.3 mL |
Reconstitution
Water volume3 mLConcentration3.33 mg/mLAdministrationSubcutaneousFrequencyOnce daily during loading (weeks 1–8), then 1–2 times weekly for maintenance in the reference protocol.Cycle length6–8 weeks initial loading, then ongoing maintenance dosing in the reference protocol.
≈3.33 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 10 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Binds melanocortin receptors, particularly MC1R and MC4R, in the cited research.
Storage
−20°C or below, dark and dry. 2–8°C, use within 1–2 weeks.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- A published case report describes toxicity at a 6 mg single dose — the reference schedule above stays well below that level.
References
Dorr RT et al. (1996) — Phase I clinical dosing and safety↗Nelson ME et al. (2012) — toxicity case report↗
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source